Cauldron
PrivateLast Round
Series A
Extension
Mar 25, 2026
Total Funding Raised
$31.06M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Cauldron operates in Healthcare & Life Sciences and is based in Orange. Its latest recorded funding round was a Series A Extension round in March 2026.
Cauldron is a biotechnology company that provides precision fermentation and biomanufacturing services to help food, fuel, and chemical producers scale their bio-based products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cauldron Comparables
Compare Cauldron with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ScaleUp Bio | 86% | |
| Planetary | 85% | |
| Liberation Bioindustries | 85% |
For institutional investors. Book with your work email.
Cauldron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 25, 2026 | ||||
| Grant | Nov 14, 2024 | ||||
| Grant | Oct 2, 2024 | ||||
| Grant | Aug 10, 2024 | ||||
| Series A | Mar 19, 2024 | ||||
Seed | Mar 29, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cauldron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series A Extension, Seed, Series A |
| Main Sequence | Series A, Seed |
| Main Sequence Ventures | Series A Extension, Seed |
| Queensland Government | Grant |
| U.S. Department of War | Grant |
| NGS Super | Series A Extension |
| In-Q-Tel | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2026
Grew 16% QoQ, from 19 to 22 employees.
- Aug 20, 2026
Monthly visitors increased 69% MoM.
For institutional investors. Book with your work email.
Cauldron Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cauldron's valuation, stock price, and market status.
Is Cauldron a public or private company?
Cauldron is a private company.
What is the current stock price of Cauldron?
Cauldron is a private company, so its shares have no public market price. Caplight tracks Cauldron's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cauldron worth (valuation)?
Valuation information for Cauldron is not publicly available.
Can I buy Cauldron stock?
Cauldron shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cauldron's last funding round?
Cauldron's most recent funding round was Series A Extension on March 25, 2026.
Who are the main investors in Cauldron?
Key investors in Cauldron include Horizons Ventures, Main Sequence, Main Sequence Ventures, Queensland Government.
Will Cauldron IPO soon?
No public IPO plans have been announced for Cauldron.
How can I track Cauldron secondary market activity?
Caplight tracks bids, offers, and trades in Cauldron's shares on secondary markets.